Evidence map›Paper›PMID 37425628›Full record

ArticleRSC advances2023

Study on the effect of fluorinated solvent electrolyte on the active material and cycle performance of a commercial 21700-type battery.

Wenbin Liu, Xinyu Li, Yingcai Zhao, Lan Wu, Shu Hong

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wenbin LiuTianjin Lishen Battery Joint-Stock Co., Ltd Tianjin 300000 China hong_shu@lishen.com.cn.ORCID https://orcid.org/0009-0007-8178-5960
Xinyu LiTianjin Lishen Battery Joint-Stock Co., Ltd Tianjin 300000 China hong_shu@lishen.com.cn.
Yingcai ZhaoTianjin Lishen Battery Joint-Stock Co., Ltd Tianjin 300000 China hong_shu@lishen.com.cn.
Lan WuTianjin Lishen Battery Joint-Stock Co., Ltd Tianjin 300000 China hong_shu@lishen.com.cn.
Shu HongTianjin Lishen Battery Joint-Stock Co., Ltd Tianjin 300000 China hong_shu@lishen.com.cn.
Lishen (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Different electrolyte schemes were studied on the traditional commercial 21700-type battery. The effect of different fluorinated electrolytes on the cycle performance of the battery was systematically investigated. When methyl (2,2,2-trifluoroetyl) carbonate (FEMC) was introduced, due to the low conductivity of FEMC, the polarization and internal resistance of the battery increased, which leads to the increase of constant voltage charging time, leading to the cracking of the cathode material and reduction of the cycle performance. When ethyl difluoroacetate (DFEA) was introduced, the poor chemical stability caused by its low molecular energy level led to the decomposition of the electrolyte. Thus, affecting the cycle performance of the battery. However, the introduction of fluorinated solvents can form a protective film on the surface of the cathode, which can effectively inhibit the dissolution of metal elements. The fast-charging cycle of commercial batteries is generally set at 10-80% SOC, which can effectively reduce the H2 to H3 phase transformation process, and the temperature rise caused by fast-charging can also reduce the effect of electrolytic conductivity, so that the protective effect of the fluorinated solvent on the cathode material is dominant. Therefore, the fast-charging cycle performance is improved.

Identifiers

PMID37425628
PMCPMC10323540
OpenAlexW4383425100

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.